HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Correspondence: Submit a response Alert me when this article is cited Alert me when Correspondence are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kleopa, K. A. Articles by Christodoulou, K. Search for Related Content PubMed PubMed Citation Articles by Kleopa, K. A. Articles by Christodoulou, K. Related Collections Peripheral neuropathy All Genetics

Phenotypic and cellular expression of two novel connexin32 mutations causing CMT1X

From the Department of Clinical Neurosciences (K.A.K., E.Z.-P., X.A., T.K.), Molecular Genetics Department D (P.N., D.-M.G., K.C.), and Department of Molecular Pathology (A.H.), The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.

Address correspondence and reprint requests to Dr. Kleopas A. Kleopa, The Cyprus Institute of Neurology and Genetics, P.O. Box 23462, 1683 Nicosia, Cyprus; e-mail: kleopa{at}cing.ac.cy

Objective: To determine the phenotypic and cellular expression of two novel connexin32 (Cx32) mutations causing X-linked Charcot–Marie–Tooth disease (CMT1X).

Methods: The authors evaluated several members of two families with CMT1X clinically, electrophysiologically, pathologically, and by genetic testing. The Cx32 mutations were expressed in vitro and studied by immunocytochemistry.

Results: In both families, men were more severely affected than women with onset in the second decade of life. In the first family, the phenotype was that of demyelinating polyneuropathy with variable involvement of peripheral nerves. There was clinical evidence of CNS involvement in at least three of the patients, with extensor plantar responses and brisk reflexes. In the second family, the affected man presented with symmetric polyneuropathy and intermediate slowing of conduction velocities, whereas affected women had prominent asymmetric atrophy of the leg muscles. The authors identified two novel missense mutations resulting in L143P amino acid substitution in the first family and in V140E substitution in the second family, both located in the third transmembrane domain of Cx32. Expression of these Cx32 mutations in communication-incompetent HeLa cells and immunocytochemical analysis revealed that both mutants were retained intracellularly and were localized in the Golgi apparatus. In contrast to wild-type protein, they did not form gap junctions.

Conclusion: These novel connexin32 (Cx32) mutations cause a spectrum of clinical manifestations characteristic of Charcot–Marie–Tooth disease (CMT1X), including demyelinating or intermediate polyneuropathy, which is often asymmetric, and CNS involvement in one family. The position and cellular expression of Cx32 mutations alone cannot fully predict these phenotypic variations in CMT1X.

Supported by a National Multiple Sclerosis Society (USA) grant (to K.A.K.) and by a Muscular Dystrophy Association (USA) grant (to K.C.).

Disclosure: The authors report no conflicts of interest.

Received July 6, 2005. Accepted in final form October 24, 2005.

This article has been cited by other articles:

				I. Sargiannidou, N. Vavlitou, S. Aristodemou, A. Hadjisavvas, K. Kyriacou, S. S. Scherer, and K. A. Kleopa Connexin32 Mutations Cause Loss of Function in Schwann Cells and Oligodendrocytes Leading to PNS and CNS Myelination Defects J. Neurosci., April 15, 2009; 29(15): 4736 - 4749. [Abstract] [Full Text] [PDF]